By Joe Paradza | Allied Health Leader & Healthcare Economics Analyst Therapy Insights, Independent Australian Publication
Published: 28 March 2026

Imagine delaying care for one month. A persistent cough. An elevated blood pressure reading you noticed at the pharmacy. A follow-up appointment you rescheduled when the fuel bill arrived and the gap fee felt impossible this week.

One month is not a crisis. It rarely feels like one. The cough persists but does not escalate. The blood pressure, you tell yourself, was probably a bad reading. The follow-up can wait until next pay cycle.

Now imagine that same decision, made by millions of people simultaneously, in the United States, the United Kingdom, Australia, Canada, and dozens of other countries where cost-of-living pressures, rising fuel prices, declining bulk billing rates, expiring insurance subsidies, and eroding public health investment have made routine care increasingly unmanageable for an increasingly large proportion of the population.

The individual deferral is a personal financial decision. The aggregate is a future healthcare crisis, assembling itself quietly, invisibly, in the weeks and months before it becomes visible in the data that health systems actually track.

This is what that scenario looks like, month by month, grounded in what the clinical evidence and system data tell us about how deferred care moves through populations and health systems.

The first month of a sustained affordability squeeze does not look like a health crisis. It looks like rational financial behaviour.

Households facing compressed budgets make the same calculation that millions already make routinely: the medical appointment is deferred because the cost, the gap fee, the fuel, the time off work, cannot be accommodated this fortnight. Preventive care visits are the first to go. Annual check-ups, routine screening appointments, non-urgent specialist follow-ups, and allied health sessions, occupational therapy, physiotherapy, mental health reviews, are the categories that feel most discretionary in a financial emergency, even when they are not.

In 2024, approximately one in six US adults, 17 percent, reported delaying or going without medical care, prescription drugs, or mental health care due to cost. In a scenario where costs intensify further, as they have in 2026, with fuel prices elevated, insurance premiums rising, and household budgets compressed, that proportion expands. The people who were previously marginal decisions become definite deferrals. And the people who were previously comfortable become marginal.

At the Month 1 mark, the system does not register this. Clinics see slightly lower appointment volumes. GPs notice more rescheduled appointments than usual. Some allied health providers begin reporting reduced bookings. Emergency departments are operating normally. There is no data signal that a system-level problem is forming.

This invisibility is the defining feature of early-stage access failure. The appointments that do not happen do not generate records. The conditions that are not being managed do not appear in the system until they do, at a significantly later stage, in a significantly more acute setting.

By the third month, the clinical consequences of sustained deferral begin to accumulate in the population of people managing chronic illness.

Ninety percent of the United States' $4.9 trillion in annual healthcare expenditure is for people with chronic and mental health conditions. The management of those conditions depends on consistent access to primary care, regular monitoring, medication reviews, blood work, lifestyle support, and the early detection of deterioration before it becomes acute. When that consistent access is disrupted by three months of financial deferrals, the conditions begin to drift.

Blood pressure that was well-controlled begins to creep upward, undetected. Diabetes management without regular HbA1c monitoring loses its feedback loop. Mental health conditions that were stable with fortnightly check-ins begin to destabilise without them. Respiratory conditions managed through regular review begin to exacerbate more frequently, without the early intervention that would previously have prevented the escalation.

Evidence across chronic obstructive pulmonary disease, chronic kidney disease, diabetes, and cancer consistently indicates that delayed diagnosis is associated with higher exacerbation and complication rates, increased hospitalisations, worse health-related quality of life, and higher mortality risk.

The system begins to register early signals at Month 3, not in emergency departments yet, but in unplanned GP presentations when patients who have deferred routine care present with conditions that have progressed further than they would have if managed consistently. Medication adherence data begins to show gaps. Pharmacy dispensing patterns shift. Clinicians begin reporting more complex presentations than would typically accompany the conditions they are treating.

For the healthcare workforce, Month 3 also brings the beginning of provider-side pressure. Community care providers operating under fixed-price funding agreements, NDIS support budgets, aged care packages, home nursing contracts, begin absorbing rising operational costs without corresponding funding increases. Fuel costs, particularly for mobile care workers in regional areas, are eating into margins that were already thin. Some providers begin making quiet decisions about service scope and geographic reach. The reach of community care begins, imperceptibly, to contract.

By the sixth month, the deferred conditions and the disrupted chronic disease management of the preceding months begin arriving at emergency departments.

Emergency department volumes in the United States reached approximately 139.8 million visits in 2024, 42.7 visits per 100 people, and projections from Sg2's 2025 Impact of Change Forecast indicate ED volumes will grow 5 percent over the next decade, driven by access barriers and rising clinical acuity. A sustained affordability squeeze accelerates that growth curve. Conditions that would have been managed at the primary care level, and that would have generated a GP visit record, not an emergency presentation, arrive instead in emergency settings, at a higher level of clinical complexity and at significantly higher system cost.

Over 90 percent of emergency departments routinely report crowded conditions. The primary cause is boarding: holding patients in the emergency department after admitting them to the hospital, because no inpatient beds are available. When the volume of presentations increases, as it does when primary care access narrows, boarding worsens. And when boarding worsens, the emergency department's capacity to manage genuinely acute presentations diminishes.

The consequence is a compounding dynamic: more patients arriving with more complex conditions because primary care was inaccessible, driving longer waits and worse triage outcomes for everyone in the system, including those with conditions unrelated to the affordability squeeze. The system does not fail for one category of patient. It degrades for all of them.

Heart disease and stroke kill more than 843,000 Americans every year, costing the healthcare system $233.3 billion annually. Costs from cardiovascular diseases are projected to reach roughly $2 trillion by 2050. A sustained period of reduced cardiovascular monitoring and management, at the six-month mark, will be contributing to that trajectory, in ways that are not detectable in the data until the mortality statistics are compiled, months or years later.

At Month 6, the mental health dimension also becomes acutely visible. Mental health conditions that were deferred in Month 1, because the financial case for the appointment was marginal, have, in many cases, progressed to crisis point. Behavioural health patients have the highest emergency department length of stay, an average of 9 to 10 hours compared to 4 to 5 hours for all ED patients. The Sg2 Impact of Change Forecast projects a 12 percent growth rate in behavioural health patients' visits to the emergency department over the next 10 years. A sustained access failure accelerates this trajectory significantly.

By Month 12, what began as an individual-level financial decision is visible as a structural health system problem.

Late-stage diagnoses begin to surface in oncology data, cancers detected at more advanced stages than baseline because screening attendance declined during the period of affordability pressure. Research on cancer treatment delays confirms associations between delayed treatment and advanced disease at diagnosis, higher morbidity and mortality risks, loss of productivity, and increased healthcare costs. Screening rates that declined at Month 1, for financial reasons, are generating oncology presentations at Month 12 and beyond that carry worse prognoses and require more intensive, more expensive treatment pathways.

Cardiovascular mortality begins to show an uptick in monthly data for populations with the highest rates of chronic disease management disruption. Preventable hospitalisations, for conditions like poorly controlled diabetes, hypertension, asthma, and heart failure, increase across all age groups but concentrate most acutely in lower-income populations, regional communities, and those who were managing their conditions at the margins of system capacity before the access pressure intensified.

WHO Europe data indicates that noncommunicable diseases cause 1.8 million avoidable deaths and cost $514 billion every year across the European region alone. Forty percent of avoidable NCD deaths are from treatable causes where death could be prevented or delayed with timely diagnosis and access to quality care. A sustained reduction in that access, even for a twelve-month period, moves measurable numbers of people from the "treatable and managed" category to the "preventable death" category in those statistics.

The US proposed FY 2026 budget for the Centers for Disease Control and Prevention amounts to a 53 percent reduction in funding compared to FY 2024, with over 100 public health programs and funding lines facing elimination, including cancer, diabetes, heart disease, and stroke prevention programs. In a scenario where access to preventive care is simultaneously narrowing at the household level and the public health infrastructure supporting population-level prevention is contracting, the compounding effect is not additive. It is multiplicative.

By Month 12, the workforce dimension has also become structural. Community care providers who contracted their geographic reach at Month 3 have, in many cases, formalized those contractions into permanent service model changes. The providers who made quiet decisions about which patients and which areas they could continue to serve have made those decisions sticky, because the infrastructure to reverse them requires capital and certainty that the funding environment has not provided.

Hospitals that expanded their emergency capacity to absorb the surge of Month 6 are now carrying the financial and staffing burden of that expansion without a corresponding increase in operating funding. Hospital expenses in the United States grew 7.5 percent in 2025, more than twice the rate of growth in hospital prices over the same period, with workforce costs rising 5.6 percent as hospitals increased wages to recruit and retain nurses, physicians, and other staff. The financial pressure on hospitals managing higher volumes of more complex patients, without proportional funding increases, is accelerating the closure of lower-margin services, often the primary care and community-facing programs that would have prevented many of those presentations if they had remained accessible.

The system has not collapsed. But it has restructured itself around the crisis, in ways that make the next crisis harder to absorb and the path back to adequate primary and preventive access longer to travel.

This scenario is not hypothetical in the sense of being entirely speculative. Elements of it are already observable in countries where the access pressure has been building for longer or has intensified more sharply.

The OECD has documented over three million premature deaths in 2023 among people under 75 that could have been avoided through better prevention and healthcare interventions. Those deaths did not occur because the treatments did not exist. They occurred because the access to timely diagnosis and management, the exact access that narrows under sustained affordability pressure, was absent when it was needed.

The global fuel crisis of 2026, documented in our analysis of the global energy disruption and its systemic implications, has added a new and acute layer of access pressure on top of the structural access problems that were already widening across the developed world. Higher fuel prices elevate the effective cost of every healthcare visit. They compress the operating margins of every mobile care provider. They make rural and regional access, already more difficult and more expensive than urban access, measurably harder to sustain.

The global healthcare access crisis is not a single event that will resolve cleanly. It is an accumulation. Each month of deferred care adds to a liability that health systems will eventually pay, in emergency departments, in hospital wards, in oncology units, in disability services, and in mortality statistics. The question is not whether that liability will be paid. It is when, and at what scale, and how many of the deaths and disabilities that accumulate during the deferral period will be preventable in retrospect.

Nearly one in five US adults, 18 percent, report that their health got worse because they skipped or delayed getting care. Among uninsured adults, that figure rises to 42 percent. These are not projections. They are current measurements of a process already underway, a process that deepens when affordability pressure intensifies and extends.

The 12-month scenario described here is, in this sense, not a warning about a future that might occur. It is a description of a trajectory that is already in motion, one that most health systems are not yet structured to interrupt at the scale required.

Australia enters this scenario from a position that combines structural vulnerability with genuine policy effort, a combination that makes the Australian trajectory particularly instructive.

The structural vulnerability is well-documented. Australia holds approximately 26 days of diesel and 29 days of petrol in reserve, well below the International Energy Agency's recommended 90-day minimum. The country imports approximately 90 percent of its refined fuels. Two refineries remain where there were once eight. Regional and rural communities pay higher fuel prices, travel greater distances for healthcare, and carry higher rates of chronic disease than metropolitan populations.

The policy effort is also real. The Australian Government's $7.9 billion investment in expanded bulk billing incentives from November 2025 represents a significant structural response to the GP access affordability problem. Emergency reserve releases, additional cargo orders, and national cabinet coordination have provided short-term fuel supply stabilisation.

But as Therapy Insights has examined, the fuel crisis is quietly shutting down disability care in ways that reserve releases do not address. Australia's fuel crisis is already reducing the operational viability of community and disability care providers, through margin erosion, geographic contraction, and the quiet, unrecorded deferral of care for some of the most vulnerable people in the system.

In the 12-month scenario, Australia's projection follows the global pattern but with the specific texture of a highly geographically distributed care system, a thin reserve position, a mobile care workforce dependent on diesel, and a regional population that was already carrying access disadvantage before the current crisis intensified it.

Month 1 looks like higher fuel costs and deferred regional appointments. Month 3 looks like community care providers reducing their service footprint. Month 6 looks like elevated emergency presentations in regional centres. Month 12 looks like structural changes to rural service delivery models that take years, not months, to reverse.

The policy question for Australia, as for every country in this position, is whether the interventions being made at the supply level are matched by interventions at the access level: the real costs, borne by real households and real providers, of getting care to people who need it across the distances and cost structures that characterise the Australian geography. 

This 12-month scenario is structured around evidence, not catastrophism. Each stage describes consequences that clinical literature and health system data already document as the observable outcomes of sustained access failure. The scenario is not extreme. It is, in many respects, a description of what is already occurring in systems where affordability pressure has been intensifying for longer than twelve months.

The important insight the scenario offers is not about collapse, health systems in wealthy countries are resilient enough to absorb a great deal before they formally fail. The insight is about the gradient. The slide from accessible care to conditional care to effectively inaccessible care does not require a dramatic system failure. It requires only that the cost barriers, transport barriers, geographic barriers, and wait time barriers accumulate, quietly, without fanfare, in ways that no single policy intervention addresses, until the aggregate effect is a population that is measurably less healthy than it would have been if access had been maintained.

The OECD has stated directly: "To enhance the effectiveness and fiscal sustainability of our healthcare systems, countries should increase the share of total health spending they allocate to preventive and primary healthcare interventions, currently just 3 percent for prevention and 14 percent for primary care."

The scenario described here is what happens when that investment is not made. Not all at once. Month by month, deferral by deferral, condition by condition, death by death, accumulating in the gap between the system that exists and the system that access to timely, affordable care would have made possible.

The data is clear on what prevention and early access deliver. The scenario analysis is equally clear on what their absence costs. The distance between those two outcomes is a policy choice, one that health systems across the developed world are, in 2026, being forced to confront more urgently than at any point in recent memory.

About Author:
Joe Paradza is an Allied Health Leader and Healthcare Economics Analyst. He writes on healthcare economics, disability service delivery, and access policy for Therapy Insights, an independent Australian publication covering the forces shaping care delivery across Australia.

Related reading:
→ People Are Skipping Healthcare Because They Can't Afford It — A Global Crisis Is Emerging
→ What Happens When You Delay Medical Care? The Hidden Health Risks Most People Ignore
→ Healthcare Is Becoming a Luxury — And Most Systems Aren't Ready for What Comes Next
→ Australia's Fuel Crisis Is Quietly Shutting Down Disability Care